Alkermes Plc (ALKS)
48.87
+0.54
(+1.12%)
USD |
NASDAQ |
Aug 24, 16:00
48.85
-0.02
(-0.04%)
After-Hours: 20:00
Alkermes Net Income (Quarterly) : 0.501M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.501M |
| March 31, 2026 | -66.48M |
| December 31, 2025 | 49.34M |
| September 30, 2025 | 82.76M |
| June 30, 2025 | 87.10M |
| March 31, 2025 | 22.46M |
| December 31, 2024 | 145.74M |
| September 30, 2024 | 92.80M |
| June 30, 2024 | 94.66M |
| March 31, 2024 | 38.95M |
| December 31, 2023 | 160.55M |
| September 30, 2023 | 47.76M |
| June 30, 2023 | 237.06M |
| March 31, 2023 | -12.05M |
| December 31, 2022 | 17.18M |
| September 30, 2022 | -63.97M |
| June 30, 2022 | -30.14M |
| March 31, 2022 | -35.90M |
| December 31, 2021 | 0.873M |
| September 30, 2021 | -28.99M |
| June 30, 2021 | 2.364M |
| March 31, 2021 | -22.42M |
| December 31, 2020 | -42.64M |
| September 30, 2020 | -0.134M |
| June 30, 2020 | -29.43M |
| Date | Value |
|---|---|
| March 31, 2020 | -38.65M |
| December 31, 2019 | -5.354M |
| September 30, 2019 | -52.88M |
| June 30, 2019 | -41.99M |
| March 31, 2019 | -96.40M |
| December 31, 2018 | -9.713M |
| September 30, 2018 | -34.44M |
| June 30, 2018 | -32.65M |
| March 31, 2018 | -62.50M |
| December 31, 2017 | -9.789M |
| September 30, 2017 | -36.28M |
| June 30, 2017 | -43.00M |
| March 31, 2017 | -68.88M |
| December 31, 2016 | -21.14M |
| September 30, 2016 | -62.69M |
| June 30, 2016 | -47.19M |
| March 31, 2016 | -77.42M |
| December 31, 2015 | -69.38M |
| September 30, 2015 | -81.02M |
| June 30, 2015 | -46.11M |
| March 31, 2015 | -30.66M |
| December 31, 2014 | 30.51M |
| September 30, 2014 | -39.96M |
| June 30, 2014 | 3.735M |
| March 31, 2014 | -24.35M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Amarin Corp. Plc | -7.664M |
| Jazz Pharmaceuticals Plc | 192.80M |
| Prothena Corp. Plc | -18.58M |
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Biogen, Inc. | 97.50M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 496.01M |
| Total Expenses (Quarterly) | 495.51M |
| EPS Diluted (Quarterly) | 0.0029 |
| Enterprise Value | 9.104B |
| Gross Profit Margin (Quarterly) | 75.30% |
| Profit Margin (Quarterly) | 0.10% |
| Earnings Yield | 0.79% |
| Operating Earnings Yield | 1.74% |
| Normalized Earnings Yield | 1.006 |